$INNV female arousal. revenues. $0.29 Pr at

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
$INNV female arousal. revenues. $0.29
Pr at support.

Revenues Up by 289% to $443,087 for Third Quarter

logo.jpg

Shares Outstanding: 23.96M
Float: 9.82M


yahoo_finance_en-US_s_f_p_191x21_finance_2x.png

Website
logo.png

Recent trades
599675067_stockwatch.jpg

Headlines

Friday, November 14, 2014
Innovus Pharmaceuticals Provides Third Quarter 2014 Financial Results With Commercial and Corporate UpdateAccesswire (Fri 12:15PM EST)
INNOVUS PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online (Fri 6:07AM EST)

Wednesday, November 5, 2014
Innovus Pharmaceuticals Announces Its Revenue GuidanceAccesswire
INNOVUS PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online

Monday, November 3, 2014
Innovus Pharma CEO, Dr. Bassam Damaj, Featured on Wide World of Stocks TelevisionAccesswire

Tuesday, October 28, 2014
Innovus Announces the Acquisition of Vesele(R), A Safer Proprietary Oral Formualtion to Maximize Nitric Oxide's Beneficial Effects on Sexual Function and Brain HealthAccesswire

Friday, October 24, 2014
Innovus Pharmaceuticals Receives Approval for the Expanded Label Indication for its Zestra(R) Product in Canada for the Temporary Increase of Desire/Arousal in Women with Female Sexual Interest/Arousal DisorderAccesswire

Friday, October 3, 2014
INNOVUS PHARMACEUTICALS, INC. Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under anEDGAR Online (

Thursday, October 2, 2014
Innovus Pharma Announces Podium Presentation at the World Meeting of Sexual Medicine, Discussing the Clinical Efficacy of Zestra(R) in Cancer PatientsGlobeNewswire

Tuesday, September 30, 2014
INNOVUS PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online

Monday, September 29, 2014
SeeThruEquity Initiates Research Coverage on Innovus Pharmaceuticals, Inc. with a Target Price of $1.34Accesswire

Wednesday, September 24, 2014
Innovus Pharma Signs License Agreement With Sothema Laboratories for Zestra(R) and Zestra Glide(R) in the Middle East (Excluding Lebanon and Israel), North Africa and West AfricaGlobeNewswire
INNOVUS PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive AgreementEDGAR Online

Monday, September 22, 2014
Innovus Pharma Signs License Agreement With Orimed Pharma for Zestra(R), EjectDelay(TM), Sensum+(TM) and Zestra Glide(R) in CanadaGlobeNewswire
INNOVUS PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive AgreementEDGAR Online

Thursday, September 18, 2014
INNOVUS PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of EqEDGAR Online
Innovus Pharma Signs Exclusive Marketing Sales and Distribution Agreement With Tramorgan Limited to Market and Distribute Sensum+(TM) in the United KingdomGlobeNewswire

Monday, September 8, 2014
SeeThruEquity Fall Microcap Investor Conference To Be Held Sept 11, 2014Accesswire
Innovus Pharma Expands US Distribution by Signing a Non-Exclusive Sampling and Distribution Agreement With Bulu Box(R) for Zestra(R) in the USGlobeNewswire

Thursday, September 4, 2014
Innovus Pharma to Present at the 2014 Aegis Healthcare Conference in Las Vegas, NV and the See Thru Equity Fall Microcap Investor Conference in New YorkGlobeNewswire

Innovus Pharmaceuticals Inc. (INNV) Stock Research Links

INNV Board Company Profile Buy Rating Time & Sales News Filings Financials
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Baseus Debuts Innovations at IFA 2026: Earbuds to Security

Updated Category News Views 2

Baseus Pumps New Blood into Tech Gadgets Well, if you're looking for some fresh tech pumping in from Berlin, Baseus tossed out some intriguing gizmos at IFA 2026 that'll perk up your ears. We're looking at an evolution from a brand that's clawed its way from everyday accessories to a full-blown tech ecosystem—pretty ambitious, if you ask me. Baseus isn't playing small...

Continue Reading
Sunseeker Unveils 2027 LiDAR Models at IFA 2026

Updated Category News Views 1

Big Moves at IFA 2026 Sunseeker’s latest unveiling at IFA 2026 in Berlin signals a bold leap. They’re stepping beyond the usual automated mowers to unveil a comprehensive, high-tech garden ecosystem for 2027. It’s not just about lawn care anymore; it’s about integrating AI and robotics into our everyday green spaces. This isn’t just tinkering with your garden;...

Continue Reading
Roborock Expands into Pool Cleaning, Partners with Real Madrid

Updated Category News Views 4

Roborock's Strategic Leap at IFA 2026 Ah, Roborock—those smart folks who want to squeeze every second out of your day—even if it means they have to steam-blast your tile floor to free you up for something else. They've strutted their stuff at IFA 2026, and I'm not just talking robot vacuums clunking through living rooms. Nope. They're diving into pools now. What’s...

Continue Reading
Baidu Joins Shanghai-HK Connect, Expanding Reach

Updated Category News Views 3

Big News from Baidu: Connect Program Inclusion Bet you didn't see this one coming. Baidu, the titan of AI in China, just rolled out some significant buzz. Starting September 7th, their Class A ordinary shares will join the Shanghai-Hong Kong Stock Connect program, shaking things up on the Shanghai Stock Exchange. This move is set to give investors from the Chinese...

Continue Reading
Allison Ng Earns Prestigious NAPABA 'Best Under 40' Award

Updated Category News Views 1

Allison Ng's Achievement: Beyond the Legal Grind Without warning, the legal world has another star rising up through its ranks, and this time it's Allison Ng catching the spotlight. She’s tucked away in Greenberg Traurig’s Atlanta office, plugging away in pharmaceutical and medical device litigation. But every now and then, these legal eagles get a chance to spread...

Continue Reading
GreenCore AI Agents Shatter Monthly Record in Ops Surge

Updated Category News Views 0

Dispatch from the Digital Trenches GreenCore Solutions Corp. (GSC) just made a bit of a splash with those numbers any company would salivate over. We're talking 24.5 million AI agent transactions in just one month. If that doesn't jolt your morning coffee, not sure what will. AI Agents Getting Busy For those out of the loop, GSC isn't your run-of-the-mill tech outfit....

Continue Reading
Simply Good Foods Class Action: Deadline Nears

Updated Category News Views 1

Turning Points in the Simply Good Foods Saga Investing always comes with its share of heartaches, but when a company's strategic blunders land you in hot water, it's personal. Simply Good Foods (NASDAQ: SMPL) finds itself in the legal spotlight, with upcoming deadlines that investors should circle in red. If you took a hit with SMPL between October 24, 2024, and April 8,...

Continue Reading
AARP New York Promotes Affordable 'Staycation' Experiences

Updated Category News Views 2

Exploring New York Without Breaking the Bank Tough times call for creative solutions, and AARP New York is on the ball. With travel costs soaring and many older New Yorkers scrimping to make ends meet, the 'Staycation' campaign steps in with an offer too good to pass up: uncovering the gems of New York right under our noses without shelling out hefty sums. The plan? Turn...

Continue Reading
Exemplar Luxury Group Taps Gretchen Koback Pursel

Updated Category News Views 0

Changing the Game with a New Chief People Officer There’s an old saying in retail: talent rules everything. Well, Exemplar Luxury Group is doubling down on this with its appointment of Gretchen Koback Pursel as Chief People Officer. Set to take the reins on September 28, Pursel brings an impressive resume chock-full of luxury and innovative transformations from big...

Continue Reading
NOVOSENSE's Bold Performance Amid Rapid IC Demand

Updated Category News Views 1

Surge in Revenue Growth Marks a Milestone for NOVOSENSE Give a pat on the back to NOVOSENSE (HKEX: 02676), because reporting a robust 66.73% bump in first-half revenue isn't small potatoes in today's tech landscape. This translates to around $374.54 million rolling into their coffers, which is quite a spectacle if you're watching the trend of sequential revenue growth...

Continue Reading

Top 5 Most Recently Viewed Articles

BAE Systems Secures $450 Million CV90 Vehicles Contract

Updated Category News Views 156

BAE Systems Wins Major Contract for Infantry Fighting Vehicles Recently, BAE Systems (LON: BA) has achieved a significant milestone by securing a contract from the Danish Ministry of Defence Acquisition and Logistics Organisation (DALO). Under this new agreement, the company will deliver an additional 44 CV90MkIIIC infantry fighting vehicles, valued at approximately $450...

Continue Reading
Viega North America Appoints New COO to Expand Operations

Updated Category News Views 122

Viega North America Welcomes New Chief Operating Officer A key executive has taken the helm at Viega North America, marking a significant step in the company’s ongoing expansion. With over 30 years of experience in the industry, Dave DeLater has been appointed as Chief Operating Officer (COO), effective immediately. Experience and Expertise DeLater's career includes...

Continue Reading
Exploring Legal Actions Around RxSight, Inc. (NASDAQ: RXST)

Updated Category News Views 99

Investigation Launched on RxSight, Inc. (NASDAQ: RXST) In a significant move, the law firm Berger Montague PC is diving deep into possible securities law violations concerning RxSight, Inc. This investigation arises following a recent class action lawsuit that targets the company. Investors who acquired stocks during a specific period may want to pay close attention as...

Continue Reading
Spring Inventory Increases: A Cautious Home Buying Landscape

Updated Category News Views 136

Spring Housing Market Trends This season, the housing market exhibits signs of rebounding, with new listings reaching the highest level for March in three years, marking a 10.2% annual increase. Despite this promising growth, buyers remain cautious. The number of pending home sales saw a decline of 5.2% year-over-year in larger metro areas, reflecting hesitance among...

Continue Reading
KalVista Pharmaceuticals Showcases EKTERLY® Insights at Congress

Updated Category News Views 190

KalVista Pharmaceuticals to Present EKTERLY® Data KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) recently announced the acceptance of six informative abstracts for ePoster presentation at a significant allergy congress. This event provides a platform for discussing advancements in the treatment of hereditary angioedema (HAE) and will take place at the German Allergy...

Continue Reading